Covid-19: Brazil seeks surplus Astra/Zeneca vaccines from U.S. and U.K.

These countries were selected because both are in advanced immunization stages and have a vaccine approved by ANVISA. Both Washington and London seek to curb the Chinese vaccine diplomacy and expand their number of partner countries.

RIO DE JANEIRO, BRAZIL - Fast vaccination pace in these countries and controversies over AstraZeneca/Oxford immunizers open the possibility for surplus doses to be sent to the government.

After creating diplomatic conflicts with China - such as Economy Minister Paulo Guedes saying that the novel coronavirus had been created by the Chinese - the Brazilian government is now seeking international deals to acquire surplus vaccine doses in countries with a fast-paced immunization program.

On the Brazilian radar there are two potential 'targets': Subscribe to our Premium Membership Plan. Already Subscribed?